These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 27893588
1. Suite PET/CT neuroimaging for the diagnosis of Parkinson's disease: statistical parametric mapping analysis. Wang R, Xu B, Guo Z, Chen T, Zhang J, Chen Y, Zhu H. Nucl Med Commun; 2017 Feb; 38(2):164-169. PubMed ID: 27893588 [Abstract] [Full Text] [Related]
2. Adenosine A1 receptors measured with 11 C-MPDX PET in early Parkinson's disease. Mishina M, Ishii K, Kimura Y, Suzuki M, Kitamura S, Ishibashi K, Sakata M, Oda K, Kobayashi S, Kimura K, Ishiwata K. Synapse; 2017 Aug; 71(8):. PubMed ID: 28407307 [Abstract] [Full Text] [Related]
6. PET evaluation of the relationship between D2 receptor binding and glucose metabolism in patients with parkinsonism. Nakagawa M, Kuwabara Y, Taniwaki T, Sasaki M, Koga H, Kaneko K, Hayashi K, Kira J, Honda H. Ann Nucl Med; 2005 Jun; 19(4):267-75. PubMed ID: 16097635 [Abstract] [Full Text] [Related]
8. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study. Nurmi E, Bergman J, Eskola O, Solin O, Hinkka SM, Sonninen P, Rinne JO. J Cereb Blood Flow Metab; 2000 Nov; 20(11):1604-9. PubMed ID: 11083235 [Abstract] [Full Text] [Related]
9. The diagnostic value of minor salivary gland biopsy in clinically diagnosed patients with Parkinson's disease: comparison with DAT PET scans. Gao L, Chen H, Li X, Li F, Ou-Yang Q, Feng T. Neurol Sci; 2015 Sep; 36(9):1575-80. PubMed ID: 25820147 [Abstract] [Full Text] [Related]
10. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease. Luo G, Shi X, Jiang L, Wu L, Yi C, Xian W, Liu Y, Wen F, Qian H, Chen J, Fu X, Liu J, Zhang X, Chen L. Brain Behav; 2023 Aug; 13(8):e3172. PubMed ID: 37459244 [Abstract] [Full Text] [Related]
12. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease. Rinne OJ, Nurmi E, Ruottinen HM, Bergman J, Eskola O, Solin O. Synapse; 2001 Jun 01; 40(3):193-200. PubMed ID: 11304757 [Abstract] [Full Text] [Related]
18. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET. Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO. Synapse; 2003 Jun 01; 48(3):109-15. PubMed ID: 12645035 [Abstract] [Full Text] [Related]
19. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, Callahan RJ, Barrow SA, Graham W, Meltzer PC, Hanson RN, Madras BK. Synapse; 1998 Jun 01; 29(2):128-41. PubMed ID: 9593103 [Abstract] [Full Text] [Related]